Profund Advisors’s Aura Biosciences AURA Stock Holding History

Profund Advisors’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$93.8K	Buy	+14,940	New	+$107K	﹤0.01%	1072

Other funds holding AURA

Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Regency Capital Management Honolulu, Hawaii $247M AUM 24.61% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

TBH Global Asset Management Brentwood, Tennessee $571M AUM 20.57% 1-Year Est. Return

Profund Advisors's AURA Position: Q3 2026 in Review

Profund Advisors opened a new position in Aura Biosciences (AURA) in Q3 2026: 14,940 shares worth $93.8K. The stake represents ﹤0.01% of the portfolio and ranks #1072 among its holdings.

53 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

Profund Advisors held 14,940 shares of Aura Biosciences worth $93.8K as of Q3 2026.
Aura Biosciences was a new Profund Advisors position in Q3 2026.
Aura Biosciences made up ﹤0.01% of Profund Advisors's portfolio in Q3 2026, its #1072 holding.
53 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.